Anticoagulant Reversal Drugs Market is expected to reach US$ 2,276.54 Mn by 2027

Published Date: 28 Jan 2021

Report : Anticoagulant Reversal Drugs Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product (Prothrombin Complex Concentrates, Vitamin K, Protamine, Tranexamic Acid, Idarucizumab, and AndeXXa), and Distribution channel (Hospital Pharmacies, Retail Pharmacies, and Others) and Geography.

Hospital Pharmacies to Register Highest CAGR in Anticoagulant Reversal Drugs Market During Forecast Period

 

According to our new market research study on “Anticoagulant Reversal Drugs Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Product, and Distribution channel,” the market is expected to reach US$ 2,276.54 million in 2027 from US$ 922.55 in 2019; it is estimated to grow at a CAGR of 12.6% from 2020 to 2027. The report highlights trends prevailing in the global anticoagulant reversal drugs market, and the factors governing the market growth.

 

Based on distribution channel, the anticoagulant reversal drugs market is segmented into hospital pharmacies, retail pharmacies, and others. The hospital pharmacies segment held the largest share of the market in 2019, and is estimated to register the highest CAGR in the market during the forecast period. Hospital pharmacies offer complex and specialized medicines, which may not be available in a retail pharmacy. It ensures the availability of right medication, in the right dose and at the right time. These factors are expected to contribute to the growth of the market during the forecast period.

 

The global anticoagulant reversal drugs market growth is mainly attributed to the rising prevalence of atrial fibrillation (AFib) and stroke. However, the high cost of anticoagulant reversal drugs is restricting the market growth.

 

Boehringer Ingelheim International GmbH; Pfizer Inc; Octapharma AG; Amag Pharmaceuticals, Inc; Fresenius Kabi AG; Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals); CSL Limited; China Biologic Products, Inc; Grifols, S.A; and Shanghai RAAS Blood Products Co., Ltd are among the key companies in the anticoagulant reversal drugs market.  

 

Anticoagulant Reversal Drugs Market, by Region, 2019 (%)

Anticoagulant Reversal Drugs Market, by Region, 2019 (%)

 

The report segments global anticoagulant reversal drugs market as follows:

 

By Product

  • Prothrombin Complex Concentrates
  • Vitamin K
  • Protamine
  • Tranexamic Acid
  • Idarucizumab
  • AndeXXa

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • UK
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Middle East and Africa (MEA)
    • Saudi Arabia
    • UAE
    • South Africa
    • Rest of Middle East and Africa
  • South and Central America (SCAM)
    • Brazil
    • Argentina
    • Rest of South and Central America
Contact Us
Contact Person: Sameer Joshi 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com   
Download Free PDF Brochure